title: Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment.
abstract: OBJECTIVE
  In recent years, quality of life (QoL) assessments have proved useful for evaluating and comparing drug treatment programs. To compare QoL of patients maintained on methadone versus slow-release morphine, a prospective, randomized, double-blind, double-dummy, cross-over study was conducted.
  
  
  METHODS
  Over two 7-week study phases, participants received either oral slow-release morphine capsules followed by methadone oral solution or vice versa. QoL status was assessed at baseline, week 7, and week 14 using the German version of the Lancashire Quality of Life Profile.
  
  
  RESULTS
  No statistically significant difference was found between methadone and slow-release morphine in any QoL domain. A significant time effect for nearly all QoL domains was observed after 14 weeks of opioid medication, independent of the chosen drug (general well-being, p < 0.001; mental health, p = 0.001; general state of health, p = 0.018; leisure time at home, p = 0.034; leisure time out of the home, p = 0.008). Furthermore, this study revealed that even short-term maintenance yields significantly higher QoL scores in the important domain of general well-being.
  
  
  CONCLUSIONS
  These results indicate that slow-release morphine has effects comparable to methadone on patient-reported QoL data and is thus a promising option for treatment of opioid-dependent subjects.
authors.affiliation: Department of Psychiatry, Medical University Vienna, Vienna, Austria.
authors.forename: Bernadette
authors.initials: B
authors.lastname: Winklbaur
authors.forename: Reinhold
authors.initials: R
authors.lastname: Jagsch
authors.forename: Nina
authors.initials: N
authors.lastname: Ebner
authors.forename: Kenneth
authors.initials: K
authors.lastname: Thau
authors.forename: Gabriele
authors.initials: G
authors.lastname: Fischer
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage; D018592:Cross-Over Studies; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage*; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D009293:Opioid-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology*; D011446:Prospective Studies; D011788:Quality of Life / Q000523:psychology*
chemical_list: D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D009020:Morphine; D008691:Methadone